MEDAX | VGAVX | MEDAX / VGAVX | |
Total Expense Ratio | 1.06 | 0.20 | 530% |
Annual Report Gross Expense Ratio | 1.07 | 0.20 | 535% |
Fund Existence | 28 years | 12 years | - |
Gain YTD | 8.997 | 10.358 | 87% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.55B | 5.52B | 137% |
Annual Yield % from dividends | 5.26 | 6.06 | 87% |
Returns for 1 year | 7.55 | 8.57 | 88% |
Returns for 3 years | 39.04 | 38.34 | 102% |
Returns for 5 years | 12.33 | 10.77 | 114% |
Returns for 10 years | 45.42 | 45.89 | 99% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CBFCX | 41.27 | 0.03 | +0.07% |
American Funds Global Balanced 529C | |||
GSIEX | 33.02 | N/A | N/A |
Goldman Sachs International Eq ESG Instl | |||
PSCZX | 25.51 | N/A | N/A |
PGIM Jennison Small Company Z | |||
MLVOX | 20.37 | N/A | N/A |
MFS Low Volatility Equity R2 | |||
LMVOX | 29.39 | N/A | N/A |
Lord Abbett Focused Small Cap Value F3 |